|Articles|April 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Melatonin Helps Treat RBD

A recent study conducted at the Mayo Clinic found that melatonin therapy was successful in patients with REM [rapid-eye-movement] Behavior Disorder (RBD). Patients with this condition are likely to act out violent dreams by screaming, kicking, punching, or jumping out of bed.

For the study, the researchers treated 14 patients with RBD and another neurologic disorder. Of the 14 patients, 10 patients reported either total control of their symptoms or showed major improvement; 2 patients initially showed improvement, but their symptoms returned; and 1 patient showed no improvement at all. After a year of treatment, a majority of the patients still showed a benefit from melatonin treatment.

Articles in this issue

over 22 years ago

RxPRODUCT NEWS PROFILE: Caduet

over 22 years ago

COMPOUNDING HOTLINE

over 22 years ago

Case Studies

over 22 years ago

Buddies Are Good for the Heart

over 22 years ago

Rage Is Connected to Stroke Risk

over 22 years ago

InnoLet

over 22 years ago

Colace/Peri-Colace

over 22 years ago

TampAlerT

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe

Related to this article

mRNA vaccine bottles and syringes for preventing coronavirus or covid-19 - Image credit: kitsawet | stock.adobe.com
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.